Photonic Viropsy: Harnessing light on chip for precise SARS-CoV-2 diagnosis
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA149258
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$426,193.52Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
THE UNIVERSITY OF ADELAIDEResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Progress in nanotechnology is driving the development of analytical tools capable of unlocking the powerful information encoded in biological fluids. Harnessing such precious information will be critical to enabling breakthroughs in the understanding and control of present and future pandemics. The project will tailor and validate a mature yet cutting-edge sensing technology specifically for integrated, precise diagnosis of SARS-CoV-2. This will allow deep insights into how concentrations of serological markers of this virus in symptomatic and asymptomatic patients are associated with the uncontrolled spread of this deadly disease & with significant benefits for addressing current and future pandemic threats to our society and economy.